Share Price
|
3
|
BIOASIS TECHNOLOGIES INC
|
Dec 14, 2018 04:17PM
|
Re: Third Eye and Topline
|
5
|
Resverlogix Corp.
|
Dec 19, 2018 10:19AM
|
Re: Difference between DSMB #7 and DSMB #8
|
1
|
Resverlogix Corp.
|
Dec 19, 2018 03:27PM
|
Novartis & Pfizer withdraw drug application in Europe
|
4
|
Resverlogix Corp.
|
Dec 23, 2018 09:20AM
|
Cardiovascular Outcomes Trials in Type 2 Diabetes
|
2
|
Resverlogix Corp.
|
Dec 27, 2018 08:48AM
|
Re: Third Eye Loan
|
4
|
Resverlogix Corp.
|
Dec 28, 2018 09:52AM
|
Re: Third Eye Loan
|
2
|
Resverlogix Corp.
|
Dec 28, 2018 10:59AM
|
Re: Third Eye Loan
|
1
|
Resverlogix Corp.
|
Dec 28, 2018 12:06PM
|
Re: Shares to Zenith
|
2
|
Resverlogix Corp.
|
Jan 03, 2019 09:18PM
|
Re: CNBC at the JPM Bio Tech Conference
|
1
|
Resverlogix Corp.
|
Jan 07, 2019 10:10AM
|
Re: CNBC at the JPM Bio Tech Conference
|
3
|
Resverlogix Corp.
|
Jan 07, 2019 10:34AM
|
Re: CNBC at the JPM Bio Tech Conference
|
2
|
Resverlogix Corp.
|
Jan 08, 2019 02:50PM
|
Re: US Patients
|
1
|
Resverlogix Corp.
|
Jan 10, 2019 05:00AM
|
Re: The waiting game.....
|
3
|
Resverlogix Corp.
|
Jan 11, 2019 01:35PM
|
Re: Deadlines missed? Results Late? Not really.
|
2
|
Resverlogix Corp.
|
Jan 12, 2019 11:13AM
|
Re: Deadlines missed? Results Late? Not really.
|
3
|
Resverlogix Corp.
|
Jan 12, 2019 05:29PM
|
Re: Sanofi Resverlogix connection?
|
1
|
Resverlogix Corp.
|
Jan 14, 2019 04:30PM
|
Re: 50 day moving average is $3.18
|
1
|
Resverlogix Corp.
|
Jan 16, 2019 06:05PM
|
Re: 50 day moving average is $3.18
|
1
|
Resverlogix Corp.
|
Jan 16, 2019 07:40PM
|
Re: 50 day moving average is $3.18
|
1
|
Resverlogix Corp.
|
Jan 17, 2019 08:31AM
|